Rx-To-OTC Switch And RWE Key To Creating ‘Crisis Proof’ European Medicines System
Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy.
You may also be interested in...
Five years in the making, the European Commission delivers its assessment of the botanical ingredients in food supplements situation, suggesting that 'traditional use' may be a way out of the deadlock.
AESGP is calling on the European Commission to ensure widening access to non-prescription drugs is a key part of its new Pharmaceutical Strategy.
The AESGP welcomes the European Commission's decision to delay the EU Medical Devices Regulation compliance deadline by one-year, and calls for a rapid increase in the number of notified bodies and the development of guidance documents.